Premier Path Wealth Partners, LLC Bristol Myers Squibb CO Transaction History
Premier Path Wealth Partners, LLC
- $656 Billion
- Q4 2024
A detailed history of Premier Path Wealth Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 33,388 shares of BMY stock, worth $2.02 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
33,388
Previous 31,520
5.93%
Holding current value
$2.02 Million
Previous $1.63 Billion
15.79%
% of portfolio
0.29%
Previous 0.26%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,573Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.4 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.62 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.63 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.72 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.7 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $129B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...